Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
Active & Responsive
Wearable Photoplethysmography for Non-invasive Hydration Assessment
for
Hydration Status
Location: Frisco TX, Plano TX
Sponsor: PepsiCo Global R&D
Sex: All
Age: 18 - 45
Code: NCT07520344
Recruiting
Active & Responsive
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
for
COVID-19
Location: Dallas TX, Lincoln NE, Columbus GA, Tempe AZ,
Sponsor: Ocugen
Sex: All
Age: 18+
Code: NCT05258669
Phase 2, Phase 3, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: Garland TX, Fort Worth TX, Tyler TX, Cedar Park TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Garland TX, Waco TX, Wichita Falls TX, Norman OK,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Active & Responsive
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
for
Treponema Pallidum, Treponema Pallidum Infection,
Location: Mesquite TX, Houston TX, St. Petersburg FL,
Sponsor: American Laboratory Products Company
Sex: All
Age: 13+
Code: NCT07089836
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Mesquite TX, Round Rock TX, Norman OK, Houston TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Fort Worth TX, Oklahoma City OK, San Antonio TX,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: Fort Worth TX, Fayetteville AR, Covington LA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase 2, Recruiting
Active & ResponsiveNew
XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors
for
Metastatic NSCLC - Non-Small Cell Lung Cancer,
Location: Fort Worth TX, Canton OH, Fairfax VA
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT07688577
Phase 1, Phase 2, Recruiting
Active & Responsive
ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer
for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC),
Location: Fort Worth TX, Los Angeles CA
Sponsor: iLeukon Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07452224
Phase 2, Recruiting
Active & Responsive
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
for
Colorectal Cancer
Location: Fort Worth TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659795
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: Antares Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07767474
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer